tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

CK Life Sciences Announces Waiver Agreement in Sale Transaction

Story Highlights
CK Life Sciences Announces Waiver Agreement in Sale Transaction

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest announcement is out from CK Life Sciences International (Holdings), Inc. ( (HK:0775) ).

CK Life Sciences International (Holdings), Inc. announced a waiver agreement regarding the sale of a target company to a purchaser. This waiver involves the Cash Settlement Right and Repurchase Right related to Purchaser Preferred Stock Payment Shares. The transaction is considered a material variation to the Sale Agreement, and the company has confirmed that the terms are fair and reasonable, aligning with the interests of the company and its shareholders.

The most recent analyst rating on (HK:0775) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on CK Life Sciences International (Holdings), Inc. stock, see the HK:0775 Stock Forecast page.

More about CK Life Sciences International (Holdings), Inc.

Average Trading Volume: 7,188,506

Technical Sentiment Signal: Buy

Current Market Cap: HK$8.75B

Learn more about 0775 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1